Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The primary objective of this study is to evaluate the development of childrens vision and neuro-devlopment 3-8 years after being treated for ROP.
Darius Moshfeghi, MD
Contact us to find out if this trial is right for you.
About this Clinical Trial
Your Message Will Go ToZac
Go Back To The Trial